Dusseldorf, Germany

Axel Drager


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 15(Granted Patents)


Company Filing History:


Years Active: 1980

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Axel Drager: Innovator in Ozonization Technology

Introduction

Axel Drager is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of ozonization technology, holding a total of 2 patents. His work focuses on the continuous ozonization of unsaturated organic compounds, which has important applications in various industries.

Latest Patents

Drager's latest patents include an "Apparatus for ozonizing unsaturated compounds" and a "Continuous process for ozonizing unsaturated compounds." These innovations describe a process and apparatus for the continuous ozonization of unsaturated organic compounds in the presence of water. The first patent outlines a method where a fresh charge mixture of unsaturated compounds is reacted in parallel flow with ozonic gas, previously used for ozonizing a partially ozonized charge mixture. The second patent details a similar process, emphasizing the simultaneous reaction of a previously partially ozonized charge mixture with fresh ozonic gas in separate reactors.

Career Highlights

Drager is currently associated with Henkel Kommanditgesellschaft Auf Aktien, commonly known as Henkel. His work at Henkel has allowed him to further develop his innovative ideas and contribute to advancements in ozonization technology.

Collaborations

Throughout his career, Drager has collaborated with notable colleagues, including Franz-Josef Carduck and Gunter Effey. These collaborations have enriched his research and development efforts, leading to impactful innovations in his field.

Conclusion

Axel Drager's contributions to ozonization technology through his patents and work at Henkel highlight his role as a significant inventor in this area. His innovative approaches continue to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…